Company Filing History:
Years Active: 2016
Title: Susanne Kinderman: Innovator in Growth Hormone Technology
Introduction
Susanne Kinderman is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of modified human growth hormone compounds. Her innovative work has the potential to transform treatment options for various growth disorders.
Latest Patents
Susanne holds a patent for "PEGylated recombinant human growth hormone compounds." This invention involves a chemically modified human growth hormone (rhGH) that is prepared by attaching a transient linker comprising polyethylene glycol. The modified protein is designed to have a longer-lasting activity compared to unmodified rhGH, which allows for reduced dosing and scheduling opportunities. Additionally, this innovation aims to minimize the risk of lipoatrophy, a common side effect associated with traditional growth hormone therapies. The patent also includes methods for treating and preventing diseases where growth hormone use is beneficial.
Career Highlights
Susanne is currently affiliated with Ascendis Pharma Growth Disorders Division A/S, where she continues to advance her research and development efforts. Her work is pivotal in addressing the needs of patients requiring growth hormone therapy.
Collaborations
Throughout her career, Susanne has collaborated with notable colleagues, including Harald Rau and Torben Lebmann. These partnerships have further enhanced her research and contributed to the success of her projects.
Conclusion
Susanne Kinderman's innovative contributions to the field of growth hormone technology exemplify her dedication to improving patient outcomes. Her patented work on PEGylated recombinant human growth hormone compounds represents a significant advancement in biotechnology.